TY - JOUR
T1 - Choosing GLP-1 receptor agonists or SGLT-2 inhibitors by cardiorenal risk
AU - Bailey, Clifford J.
PY - 2020/2/1
Y1 - 2020/2/1
UR - http://www.scopus.com/inward/record.url?scp=85078010259&partnerID=8YFLogxK
UR - https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2213858719304140?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2213858719304140%3Fshowall%3Dtrue&referrer=https:%2F%2Fpure.aston.ac.uk%2Fadmin%2Feditor%2Fdk%2Fatira%2Fpure%2Fapi%2Fshared%2Fmodel%2Fresearchoutput%2Feditor%2Fcontributiontojournaleditor.xhtml%3Fscheme%3D%26type%3D%26showMigrationIfUnknown%3Dtrue
U2 - 10.1016/S2213-8587(19)30414-0
DO - 10.1016/S2213-8587(19)30414-0
M3 - Letter, comment or opinion
C2 - 31843565
AN - SCOPUS:85078010259
SN - 2213-8587
VL - 8
SP - 97
EP - 99
JO - The Lancet Diabetes and Endocrinology
JF - The Lancet Diabetes and Endocrinology
IS - 2
ER -